Search Page

1

Cite

Share

Emerging Immunotherapies for Parkinson Disease.

Zella SMA, Metzdorf J, Ciftci E, Ostendorf F, Muhlack S, Gold R, Tönges L. Zella SMA, et al. Among authors: metzdorf j. Neurol Ther. 2019 Jun;8(1):29-44. doi: 10.1007/s40120-018-0122-z. Epub 2018 Dec 11. Neurol Ther. 2019. PMID: 30539376 Free PMC article. Review.

Cite

Share

2

Cite

Share

Short-chain fatty acids in the context of Parkinson's disease.

Metzdorf J, Tönges L. Metzdorf J, et al. Neural Regen Res. 2021 Oct;16(10):2015-2016. doi: 10.4103/1673-5374.308089. Neural Regen Res. 2021. PMID: 33642384 Free PMC article. No abstract available.

Cite

Share

3

Cite

Share

Fingolimod for Irradiation-Induced Neurodegeneration.

Metzdorf J, Hobloss Z, Schlevogt S, Ayzenberg I, Stahlke S, Pedreiturria X, Haupeltshofer S, Gold R, Tönges L, Kleiter I. Metzdorf J, et al. Front Neurosci. 2019 Jul 9;13:699. doi: 10.3389/fnins.2019.00699. eCollection 2019. Front Neurosci. 2019. PMID: 31354410 Free PMC article.

Cite

Share

4

Cite

Share

[Parkinson's disease and neuroinflammation - Cellular pathology, mechanisms and therapeutic options].

Tönges L, Metzdorf J, Zella S. Tönges L, et al. Among authors: metzdorf j. Fortschr Neurol Psychiatr. 2018 Sep;86(S 01):S10-S20. doi: 10.1055/s-0044-101608. Epub 2018 Jul 17. Fortschr Neurol Psychiatr. 2018. PMID: 30016808 Review. German.

Cite

Share

5

Cite

Share

A Propagated Skeleton Approach to High Throughput Screening of Neurite Outgrowth for In Vitro Parkinson's Disease Modelling.

Schikora J, Kiwatrowski N, Förster N, Selbach L, Ostendorf F, Pallapies F, Hasse B, Metzdorf J, Gold R, Mosig A, Tönges L. Schikora J, et al. Among authors: metzdorf j. Cells. 2021 Apr 17;10(4):931. doi: 10.3390/cells10040931. Cells. 2021. PMID: 33920556 Free PMC article.

Cite

Share

6

Cite

Share

Late running is not too late against Alzheimer's pathology.

Herring A, Münster Y, Metzdorf J, Bolczek B, Krüssel S, Krieter D, Yavuz I, Karim F, Roggendorf C, Stang A, Wang Y, Hermann DM, Teuber-Hanselmann S, Keyvani K. Herring A, et al. Among authors: metzdorf j. Neurobiol Dis. 2016 Oct;94:44-54. doi: 10.1016/j.nbd.2016.06.003. Epub 2016 Jun 14. Neurobiol Dis. 2016. PMID: 27312772

Cite

Share

7

Cite

Share

Propionic Acid and Fasudil as Treatment Against Rotenone Toxicity in an In Vitro Model of Parkinson's Disease.

Ostendorf F, Metzdorf J, Gold R, Haghikia A, Tönges L. Ostendorf F, et al. Among authors: metzdorf j. Molecules. 2020 May 28;25(11):2502. doi: 10.3390/molecules25112502. Molecules. 2020. PMID: 32481507 Free PMC article.

Cite

Share

8

Cite

Share

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease.

Zella MAS, Metzdorf J, Ostendorf F, Maass F, Muhlack S, Gold R, Haghikia A, Tönges L. Zella MAS, et al. Among authors: metzdorf j. Cells. 2019 Jan 31;8(2):105. doi: 10.3390/cells8020105. Cells. 2019. PMID: 30708997 Free PMC article. Review.

Cite

Share

9

Cite

Share

Analysis of neurogenesis during experimental autoimmune encephalomyelitis reveals pitfalls of bioluminescence imaging.

Ayzenberg I, Schlevogt S, Metzdorf J, Stahlke S, Pedreitturia X, Hunfeld A, Couillard-Despres S, Kleiter I. Ayzenberg I, et al. Among authors: metzdorf j. PLoS One. 2015 Mar 17;10(3):e0118550. doi: 10.1371/journal.pone.0118550. eCollection 2015. PLoS One. 2015. PMID: 25780928 Free PMC article.

Cite

Share